Saeed Taheri
Overview
Explore the profile of Saeed Taheri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
395
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taheri S
World J Nephrol
. 2024 Jan;
12(5):182-200.
PMID: 38230296
Background: Gliflozins or Sodium glucose cotransporter 2 inhibitors (SGLT2i) are relatively novel antidiabetic medications that have recently been shown to represent favorable effects on patients' cardiorenal outcomes. However, there is...
2.
Taheri S
Saudi J Kidney Dis Transpl
. 2023 Nov;
33(6):795-823.
PMID: 38018721
Patients with refractory or relapsed malignant disorders are in desperate condition, with few therapeutic options left, if any. Chimeric antigen receptor (CAR) transduced T-cell transplantation is a novel approach that...
3.
Ayati N, Taheri S, Sahraian M, Nikfar S
Curr J Neurol
. 2023 Nov;
20(3):154-161.
PMID: 38011445
The current study desired to conduct an economic analysis on ocrelizumab (OCR), a new relapsing multiple sclerosis (RMS) treatment strategy, in comparison to natalizumab (NTL), as one of the mostly-used...
4.
Taheri S
World J Transplant
. 2023 Sep;
13(5):250-253.
PMID: 37746039
Renal transplantation is the treatment of choice for end stage kidney disease. However, despite all the efforts to expand the donor pool, the shortage of donors is increasing and as...
5.
Taheri S
Int Urol Nephrol
. 2023 Feb;
55(4):791-802.
PMID: 36723829
Introduction: Patients under renal replacement therapy are at an increased risk of severe infection with SARS-CoV-2, and have been known to have impaired response to standard vaccination. This systematic review...
6.
Yousefi N, Salimi A, Mohammadnezhad G, Taheri S, Peiravian F
J Gastrointest Cancer
. 2023 Jan;
54(4):1212-1219.
PMID: 36622516
Purpose: This study aimed to evaluate the cost-effectiveness of cetuximab in different genetic populations of metastatic colorectal carcinoma patients, including KRAS and RAS wild types and mutants, when added to...
7.
8.
Ekhlasi M, Taheri S, Yousefi N
Value Health Reg Issues
. 2022 Sep;
32:54-61.
PMID: 36087364
Objectives: Diabetes mellitus (DM), as one of the most common metabolic diseases, is the ninth leading cause of death globally and imposes heavy costs on the health systems including both...
9.
Rezaei S, Taheri A, Taheri S, Kasirzadeh S, Fatemi B, Sorato M
Expert Rev Clin Pharmacol
. 2022 May;
15(6):767-777.
PMID: 35579011
Objectives: Performing an updated meta-analysis to compare the safety and efficacy of insulin glargine and insulin detemir in adults with type 1 and type 2 diabetes. Methods: Electronic databases were...
10.
Taheri S
World J Nephrol
. 2022 Apr;
11(2):73-85.
PMID: 35433340
Background: Nephritic syndrome (NiS) is a major indicator of serious renal diseases necessitating kidney biopsies for histopathological evaluations, but due to the lack of comprehensive reviews in the literature, the...